VAERS reports by lot

Seqirus / CSL Flu lot 195241: VAERS reports

20 VAERS reports list lot 195241 as a Seqirus / CSL Flu vaccine, received between 2017-10-16 and 2019-04-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
15%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4525%
Neurological4022%
Musculoskeletal2111%
Respiratory2011%
Injection-site / Local reaction1910%
Gastrointestinal179%
Cardiac / Cardiovascular116%
Allergic / Anaphylactic53%
Dermatological (non-injection-site)42%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Michigan2
Tennessee1
Ohio1
New York1
North Carolina1
Texas1
Oregon1
Delaware1
Minnesota1
Hawaii1
Wisconsin1

Reports by month received

2017-101
2017-115
2017-121
2018-014
2018-023
2018-051
2018-091
2019-013
2019-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.